Inhibitors of type 2 vascular endothelial growth factor receptors

Details for Australian Patent Application No. 2004296376 (hide)

International Classifications

Event Publications

27 July 2006 PCT application entered the National Phase

PCT publication WO2005/056764 Priority application(s): WO2005/056764

9 November 2006 Change of Name(s) of Applicant(s), Section 104

Compound Therapeutics, Inc. The name of the applicant has been changed to Adnexus Therapeutics, Inc.

4 October 2007 Amendment Made

The nature of the amendment is: Amend the co-inventor name from Gokemeijer, Jochim to Gokemeijer, Jochem

29 November 2007 Amendment Made

The nature of the amendment is: Add co-inventors Sun, Lin and Wittekind, Michael

18 December 2008 Assignment before Grant

Adnexus Therapeutics, Inc. The application has been assigned to Bristol-Myers Squibb Company 2005

4 March 2010 Application Accepted

Published as AU-B-2004296376

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.